权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Educating Groups Influencing Generic Drug Use

教育影响仿制药使用的群体

基本信息

批准号：
9340998
负责人：
ILENE HARRIS
金额：
$ 25万
依托单位：
AUBURN UNIVERSITY AT AUBURN
依托单位国家：
美国
项目类别：
财政年份：
2015
资助国家：
美国
起止时间：
2015-09-15 至 2019-02-28
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/9340998
关键词：
Educating Groups Influencing Generic Drug

项目摘要

Project Abstract Spending on prescription drugs in the U.S. has risen 114% since 2000. One way to combat rising prescription drug costs is to encourage use of generic drugs. Just considering U.S. Medicare and Medicaid programs, an estimated $89 billion could be saved over the next decade through expanded generic drug use. While the cost- savings of generics is clear, generic drug market penetration varies across classes of drugs, by prescribers, and by geographic location. Evidence shows that generic drug use is largely impacted by certain key groups' behaviors and perceptions towards generic drugs. While believed to be influential, the extent of each groups influence is heterogeneous and dependent on factors such as experiences and perceptions with generic drugs. Thus, effective educational efforts to target all types of barriers that may limit generic drug use are a critical need. The purpose of the proposed research is to understand roles of key groups and the extent of their influence on generic drug use in order to provide additional and effective educational outreach to meet their informational needs. To this end, we will use a mixed-methods approach to address three study aims: 1) to study the key groups influencing generic drug use in the U.S. and to determine the nature and extent of their influence; 2) to determine the key groups' informational needs regarding generic drugs and establish the current and desired means by which these key groups receive healthcare-related educational material; and 3) to develop, test, and revise educational materials to address key groups' informational needs regarding generic drugs. The six a priori defined key groups include patients/caregivers, prescribers, pharmacists, insurance formulary managers, state health policy makers, and pharmaceutical manufacturers. We will determine the nature and extent of each groups influence using systematic review combined with innovative analyses of multiple publicly available datasets. Qualitative key informant interviews will develop profiles of informational needs for generic drugs overall and for specific drug groups that have unique properties. Developmental panels combined with key informant interviews and surveys will develop and refine educational materials. The expected outcomes of this study are provision of information, strategies, and educational materials to overcome barriers to generic drug use in the U.S.

项目摘要

项目成果

期刊论文数量（7）

专著数量（0）

科研奖励数量（0）

会议论文数量（0）

专利数量（0）

Patient and caregiver opinions about an FDA-developed generic drug educational handout: A pilot cross-sectional survey.

患者和护理人员对 FDA 开发的仿制药教育讲义的看法：一项试点横断面调查。

DOI：
10.1016/j.japh.2020.10.019
发表时间：
2021
期刊：
Journal of the American Pharmacists Association : JAPhA
影响因子：
0
作者：
Hohmann,NatalieS;Poudel,Nabin;Garza,KimberlyB;Surry,Daniel;Hansen,RichardA;Harris,Ilene;Kiptanui,Zippora;Oguntimein,Oluwamurewa;Frost,MitchellM;Qian,Jingjing
通讯作者：
Qian,Jingjing

Association between Higher Generic Drug Use and Medicare Part D Star Ratings: An Observational Analysis.

较高仿制药使用与医疗保险 D 部分星级评级之间的关联：观察分析。

DOI：
10.1016/j.jval.2018.03.005
发表时间：
2018
期刊：
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
影响因子：
0
作者：
Hohmann,Natalie;Hansen,Richard;Garza,KimberlyB;Harris,Ilene;Kiptanui,Zippora;Qian,Jingjing
通讯作者：
Qian,Jingjing

Disclosure of industry payments to prescribers: industry payments might be a factor impacting generic drug prescribing.

DOI：
10.1002/pds.4224
发表时间：
2017-07
期刊：
Pharmacoepidemiology and drug safety
影响因子：
2.6
作者：
Qian J;Hansen RA;Surry D;Howard J;Kiptanui Z;Harris I
通讯作者：
Harris I

Communicating benefits and risks of generic drugs to consumers: Patient and caregiver opinions of two FDA-developed educational materials.

向消费者传达仿制药的益处和风险：患者和护理人员对 FDA 开发的两份教育材料的意见。

DOI：
10.1016/j.sapharm.2019.01.013
发表时间：
2019
期刊：
Research in social & administrative pharmacy : RSAP
影响因子：
0
作者：
Hohmann,NatalieS;Garza,KimberlyB;Surry,Daniel;Hansen,RichardA;Harris,Ilene;Kiptanui,Zippora;Oguntimein,Oluwamurewa;Frost,MitchellM;Qian,Jingjing
通讯作者：
Qian,Jingjing